pembrolizumab,Lenvatinib
eisai pharmaceutical,merck
['pembro', 'eisaius', 'eisai']
 dr. richard woodman from spoke with us on the #asco22 - phase 3 clear 3 0 7 study. len pembro outperformed in terms of pfs and os in with arrc. #oncotwitter 
Produce, Find, and Distribute the latest and highest quality  multimedia to oncologists, hematologists and researchers.